Derma Sciences: The Wound Care Company Whose Sales Representatives Coached Clinicians to Upcode Treatment Complexity

Derma Sciences Inc., a manufacturer of wound care products sold primarily through healthcare facilities to Medicare patients, agreed to pay $11.25 million to resolve False Claims Act allegations that its sales representatives routinely coached wound care clinicians — nurses, nurse practitioners, and physicians managing wound care programs — to document patient wound characteristics in ways designed to support higher-complexity billing codes for wound care services, generating inflated Medicare reimbursement for those services and increasing utilization of Derma Sciences' wound care products by clinicians who used the company's training and documentation tools.DOCUMENTED

Wound care billing under Medicare is complex and reimbursement-sensitive: the payment for wound care services varies substantially based on wound type, wound size, depth, presence of infection, and the complexity of the dressing or treatment applied. Wound care clinicians who document more complex wound characteristics — or who choose dressing products that generate higher complexity codes — receive higher Medicare reimbursement for the same patient care encounter. When a wound care product manufacturer's sales force trains clinicians on documentation practices that systematically favor higher complexity codes, the company is not simply educating clinicians about its products — it is participating in a billing scheme that inflates Medicare costs.REVIEWED

The Sales Representative Training Model

Derma Sciences' sales model involved deploying product representatives to wound care clinics, long-term care facilities, and home health agencies whose clinicians managed Medicare patients with chronic or acute wounds. Beyond selling the company's products — wound dressings, topical treatments, and related wound care supplies — the representatives conducted clinical education sessions that included guidance on documentation practices for wound care billing.DOCUMENTED

The documentation training sessions, as described in the complaint, focused on how clinicians should describe wound characteristics in their clinical notes to maximize the complexity tier of applicable billing codes. Techniques taught in the training included how to measure and document wound dimensions to reach higher surface area thresholds that triggered higher reimbursement, how to characterize wound drainage and wound bed condition in terms that qualified for more complex dressing categories, and how to select Derma Sciences' more expensive product lines by documenting wound characteristics that justified those products' use under Medicare coverage criteria.DOCUMENTED

The Billing Impact

Statistical analysis of claims submitted by facilities whose clinicians had received Derma Sciences documentation training found higher average wound complexity codes and higher rates of the most expensive wound care product categories compared to facilities not engaged in the training program. The pattern was consistent across multiple facility types — long-term care, home health, and outpatient wound care clinics — suggesting that the training was producing consistent shifts in coding behavior rather than random variation in wound complexity across different patient populations.DOCUMENTED

From the company's perspective, the documentation training served a dual commercial purpose: it increased Medicare reimbursement to the facilities using its products, making those facilities more economically satisfied customers, and it drove use of the company's higher-priced wound care products by giving clinicians a clinical documentation rationale for selecting the more expensive options over lower-priced alternatives. Both effects served Derma Sciences' revenue interests — the first by building customer loyalty through the economic benefit to the facility, and the second by directly increasing sales of the company's most profitable products.DOCUMENTED

Former sales representatives described the documentation training as a standard part of the company's account development process — not framed as an educational offering but as a sales tool that tied wound care coding optimization directly to the selection of Derma Sciences products.

Manufacturer Liability in Billing Schemes

The Derma Sciences case illustrates a theory of False Claims Act liability that applies to suppliers who do not themselves submit Medicare claims but whose actions drive inflated billing by the providers who do. When a manufacturer's sales practices — including documentation coaching, prior authorization support, or coverage justification training — are designed to generate billing for services or products that would not otherwise be billed, or to support higher-complexity billing than the clinical facts support, the manufacturer may be liable for the resulting false claims even though it did not submit those claims itself. The theory is that the manufacturer's conduct was a proximate cause of the false claims submitted by the facilities its sales team trained.REVIEWED

Healthcare product companies whose sales teams provide clinical documentation training to customers should carefully evaluate that training against this liability theory. Training that helps clinicians accurately document the clinical facts and select the appropriate billing code for those facts is legitimate education; training designed to identify documentation opportunities that will support higher-complexity billing regardless of the underlying clinical facts crosses the line into fraud facilitation. The line is not always obvious in practice, which is why wound care and medical device companies subject to this enforcement risk should have legal review of all sales representative training materials before deployment.DOCUMENTED

Wound care clinicians who received documentation training from Derma Sciences sales representatives and who believe the training they received advised documentation practices inconsistent with their patients' actual clinical presentation are encouraged to consult a healthcare compliance attorney and to contact the HHS OIG hotline. Watchdog Journal's tip channel at /tips is available for individuals with relevant documentation of the training program content.

Wound Care Compliance Best Practices

Wound care facilities that receive education from product manufacturers should carefully evaluate whether that education is focused on accurate clinical documentation of actual wound characteristics versus strategies designed to maximize billing code complexity. The distinction is not always immediately obvious when presented by a sales representative with clinical training, but it becomes clear when the documentation guidance focuses on identifying wound characteristics at or above billing thresholds rather than on accurately describing what the clinician observes. Facilities should require their billing compliance officers to review any third-party documentation training before implementing it in clinical practice, and should conduct periodic audits comparing documented wound characteristics against actual clinical photographs in the medical record to identify any systematic discrepancy between what is documented and what is observed.

Have documents relevant to this story? Reach us through our tips channel.